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ABSTRACT
Expression of CRISPR-Cas systems is a prerequisite
for their defensive role against invading genetic ele-
ments. Yet, much remains unknown about how this
crucial step is regulated. We describe a new mech-
anism controlling CRISPR-cas expression, which re-
quires an extracytoplasmic function (ECF)  factor
(DdvS), its membrane-bound anti- (DdvA) and a
global regulatory complex (CarD–CarG). Transcrip-
tomic analyses revealed that the DdvS/CarD/CarG-
dependent regulon comprises a type III-B CRISPR-
Cas system in Myxococcus xanthus. We mapped four
DdvS-driven CarD/CarG-dependent promoters, with
one lying immediately upstream of the cas cluster.
Consistent with direct action, DdvS and CarD–CarG
localize at these promoters in vivo. The cas genes
are transcribed as a polycistronic mRNA that reads
through the leader into the CRISPR array, a putative
A-dependent promoter in the leader having negligi-
ble activity in vivo. Consequently, expression of the
entire CRISPR-Cas system and mature CRISPR-RNA
(crRNA) production is DdvS/CarD/CarG-dependent.
DdvA likely uses its large C-terminal domain to
sense and transduce the extracytoplasmic signal
triggering CRISPR-cas expression, which we show
is not starvation-induced multicellular development.
An ECF-/anti- pair and a global regulatory com-
plex provide an effective mechanism to coordinate
signal-sensing with production of precursor crRNA,
its processing Cas6 endoribonuclease and other Cas
proteins for mature crRNA biogenesis and interfer-
ence.
INTRODUCTION
CRISPR (clustered regularly interspaced short palindromic
repeats) genetic loci and their associated (cas) genes
are adaptive, small RNA-guided ‘immune’ systems for
sequence-specific destruction of nucleic acids in archaea
and bacteria (1–5). Their role in the defense against foreign
genetic elements, such as plasmids and phages, has beenwell
established (6), and they have been linked to other cellu-
lar functions like gene regulation, biofilm formation, multi-
cellular development and virulence (4,7–11). They are also
providing revolutionary tools and applications, from mi-
crobes to plants and animals, for gene and genome editing
to probe gene function and regulation with unprecedented
specificity (12).
CRISPR arrays consist of a variable number (usually
<50) of short (20–50 bp) repeats separated by similarly
sized spacers of diverse sequence acquired from foreign ge-
netic material in a process called ‘adaptation’, mediated by
Cas1 and Cas2 proteins (2). During CRISPR-Cas ‘expres-
sion’, the array is usually transcribed from a promoter in the
leader region immediately upstream. This generates a long
precursor RNA (pre-crRNA) that is processed by specific
Cas endonucleases (generally expressed from a cas operon)
to small CRISPR RNAs or crRNAs. Mature crRNAs as-
semble with defined Cas proteins as a ribonucleoprotein ‘in-
terference’ complex to target nucleic acids with sequence
complementarity for degradation (6,13–16). CRISPR-Cas
systems are diverse and have been classified thus far into
two classes, six types and over 20 subtypes based on locus
arrangement and signature cas genes (1,17). Types I, III and
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IV, with multiprotein crRNA–effector complexes, are class
1 systems; types II, V and VI, with a single protein–crRNA
effector complex, are class 2. All CRISPR-Cas systems re-
quire Cas proteins and crRNAs for function, and CRISPR-
cas expression is a prerequisite to acquire new spacers, pro-
cess pre-crRNAand assemble ribonucleoprotein crRNA in-
terference complexes for target degradation (1–5,13). Yet,
much remains to be discovered about the crucial step of how
CRISPR-cas expression is triggered and controlled in vivo,
which may occur at different stages of the invasion process
(18).
Regulatable CRISPR-cas expression is desirable as it
would keep the system silent until required (as upon phage
infection), economize the cellular costs of expressing such
large clusters and avoid unwanted build-up of products,
like nucleases, that can be detrimental to the host. How-
ever, active CRISPR-cas expression in the absence of infec-
tion has been reported for Thermus thermophilus, Clostrid-
ium difficile, Pectobacterium atrosepticum and Legionella
pneumophila under a variety of laboratory growth condi-
tions (19–22). On the other hand, global regulatory fac-
tors such as H-NS (histone-like nucleoid-structuring pro-
tein) in Escherichia coli and some other species, and LRP
(leucine-responsive regulatory protein) in Salmonella enter-
ica have been implicated in CRISPR-cas repression, which
must somehow be relieved upon infection (23–26). Changes
in host metabolism in response to invasion by foreign el-
ements, sensed via the global regulators CRP (cAMP re-
ceptor protein) or LeuO (a LysR-type transcriptional fac-
tor), have also been linked to CRISPR-cas changes in ex-
pression (23,27–30). Interestingly, few specific transcription
factors have been implicated to date. These include an acti-
vator (Csa3a) and a repressor (Csa3b) in the archaeal Sul-
folobus (31–33), which are associated with or proximal to
the CRISPR-cas loci; and DevTRS in Myxococcus xan-
thus, whose genes form part of a cas operon and are in-
volved in negative autoregulation linked to spore differ-
entiation within the multicellular fruiting bodies that de-
velop upon starvation (9,11,34). Likewise, quorum-sensing
mechanisms were recently shown to regulate CRISPR-
cas expression in Pseudomonas aeruginosa and Serratia
(35,36). In many of the above bacterial systems, CRISPR-
cas transcription relies on promoters recognized by RNA
polymerase (RNAP) holoenzyme containing the primary
70/A factor (RNAP-A). Moreover, the aforementioned
regulators generally target cas gene promoters with few, if
any, CRISPR array-specific regulators known, at least in
bacteria (18). The bacterial cell envelope is at the frontline
for dealing with extracellular threats or stresses and would
be the first to sense any intrusion that triggers CRISPR-
cas activation. But this is also the least understood step,
although membrane perturbation via the two-component
systems BaeSR in E. coli (37) and VicRK in Streptococcus
mutans (38) has been linked to CRISPR-cas activation.
In the present study, we report a previously undescribed
mechanism for regulated expression of a CRISPR-Cas sys-
tem. We have discovered that an extracytoplasmic func-
tion (ECF)  factor, DdvS, drives the expression of all the
cas genes as well as of the CRISPR array of a type III-B
CRISPR-Cas system inM. xanthus, CRISPR4-Cas, one of
three such systems found in this bacterium (Figure 1A and
Supplementary Figures S1–3). ECF  factors are alterna-
tive  factors of the bacterial 70 family and generally act in
response to specific extracellular signals (39–41). Like typi-
cal ECF  factors, DdvS is negatively regulated by its spe-
cific membrane-associated anti- factor DdvA (42), which
would be expected to directly or indirectly sense and/or
transduce the signal that triggers CRISPR4-cas expression.
Our data indicate that this signal, whose identity remains
elusive, is not related to starvation, which triggers devel-
opment of fruiting bodies, since neither CRISPR4-cas ex-
pression nor mature crRNA formation was observed dur-
ing multicellular development and normal fruiting bodies
formed even when the CRISPR4-Cas system is artificially
expressed. We demonstrate that expression of the DdvS-
dependent CRISPR4-Cas system in vivo requires CarD and
CarG. These two proteins always act in unison as a com-
plex and bind to RNAP and to DNA via CarD, the found-
ing member of a large and important family of RNAP-
binding proteins with global regulatory roles, the CarD–
CarG complex itself being implicated in the action of sev-
eral ECF  factors in M. xanthus (42–49). Whereas the
only known interaction of CarG is that with the CarD N-
terminal domain, which also binds to the RNAP  sub-
unit, the CarD C-terminal domain, an intrinsically disor-
dered, eukaryotic high-mobility group A-like domain with
four AT-hook DNA-binding motifs, binds to the minor
groove of AT-rich DNA tracts to maximize CarD activity.
Our present study identified three promoters dependent on
DdvS, CarD and CarG at the CRISPR4-cas locus, besides
that of the ddvS–ddvA pair and, consistent with a direct reg-
ulatory action, we show that DdvS and CarD–CarG local-
ize at these promoters in vivo. The data also revealed that the
cas genes form an operon, which is transcribed as a single
polycistronic mRNA that reads into the CRISPR4 array.
Although the leader region contains a putative RNAP-A
promoter, its activity was negligible in vivo. Moreover, the
CRISPR4-Cas system co-expresses with the pre-crRNA a
Cas6 homolog that, we show, is required to generate ma-
ture crRNAs. Thus, an ECF-/anti- pair, together with a
global regulatory complex, effectively regulate coordinated
production of pre-crRNA, its processing Cas6 endoribonu-
clease and other Cas proteins for mature crRNA biogenesis
and interference.
MATERIALS AND METHODS
Strains, plasmids, growth conditions and strain construction
Plasmids and M. xanthus strains used in this study are
listed, respectively, in Supplementary Tables S1 and 2.Myx-
ococcus xanthus vegetative growth was carried out at 33◦C
in the rich casitone-Tris (CTT) medium (1% Casitone, 10
mM Tris–HCl pH 8.0, 1 mM KH2PO4-K2HPO4, 8 mM
MgSO4; final pH 7.6), with antibiotic (kanamycin, Km,
at 40 g/ml or oxytetracycline, Tc, at 10 g/ml) when
necessary. CTT agar (1.5%) was used for growth on solid
medium. For conditional gene expression, the medium was
supplied with inducer (0.5mMvanillate or 1mM isopropyl-
-d-thiogalactopyranoside-IPTG) as required (50). Fruit-
ing body development was induced on CF agar plates and
examined using a Zeiss dissecting microscope. For this, cells
grown in CTT to an OD550 of 0.6 (∼108 cells ml−1) were
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Figure 1. Myxococcus xanthus CRISPR-Cas systems and the DdvS regulon. (A) The threeM. xanthus CRISPR-Cas systems and their location in the 9.14
Mb circular chromosome. Colored rectangles indicate the cas gene clusters of each system, whose type is labeled below. The four CRISPR arrays and the
number of spacers in each are indicated. Vertical blue and red bars indicate genes ddvS and ddvA, respectively, and the unfilled bars are for genes encoding
hypothetical proteins. The arrow points in the direction of transcription. (B) Venn diagram representation of microarray transcriptomic data for genes
upregulated in the ddvA− strain (MR1543) relative to the WT strain (DK1622; blue), and downregulated in the ddvA− carD strain (MR1544) or in the
ddvA− carG strain (MR1545) relative to MR1543 (green and pink, respectively). Genes and microarray data with differential expression are listed in
Table 1 and Supplementary Table S4.
washed twice by centrifugation in TPM (10 mM Tris–HCl
pH 8.0, 1 mM KH2PO4-K2HPO4, 8 mMMgSO4; final pH
7.6) buffer, concentrated 10-fold in TPM buffer, spotted (10
l) on CF plates and incubated at 33◦C. Escherichia coli
DH5, used for plasmid constructions, was grown at 37◦C
in Luria broth supplemented with the appropriate antibi-
otic. Plasmids were constructed using standard protocols,
verified by DNA sequencing, and introduced into M. xan-
thus by electroporation, where they integrate by homolo-
gous recombination. Plasmids used for IPTG or vanillate-
inducible gene expression and the integrative plasmids with
a 1.38 or 1.31-kbM. xanthusDNA for integration at a chro-
mosomal site with no promoter activity have been described
elsewhere (50). Strains with in-frame gene deletions were
constructed following the two-step allele exchange proto-
col using KmR negative selection/galK positive selection
(galactose sensitivity, GalS), as described previously (50).
The polymerase chain reaction (PCR) overlap extension
method was employed for site-directed mutagenesis.
Microarray analysis
Total RNA was isolated for microarray analysis as follows.
TheM. xanthus strain of interest was grown in 50 ml CTT
to exponential phase (OD550 = 1), and 1 ml (for 5′ RACE)
or 6ml (for transcriptomic analysis) of the culture were then
pelleted by centrifugation and stored at −70◦C. Frozen cell
pellets were resuspended in 300 l of a 0.3 M sucrose/0.01
M sodium acetate pH 4.5 solution, transferred to an Ep-
pendorf tube containing 300 l of 2% sodium dodecyl sul-
fate, 0.01 M sodium acetate pH 4.5, incubated at 65◦C for
1–2 min, mixed well with 400 l of phenol and incubated
at 65◦C for 3 min after thorough mixing. After snap freez-
ing for 1–2 min in liquid nitrogen, it was thawed, then cen-
trifuged (16 000 g, 5 min) and the resulting aqueous layer
was pipetted into a fresh tube with 600 l of hot phenol.
The mixing, 3 min-incubation at 65◦C, snap-freezing in liq-
uid nitrogen, and centrifugation were repeated as before.
The aqueous phase obtained was mixed with 600 l 1:1
phenol:chloroform in a new tube and centrifuged, and the
process repeated using 600 l pure chloroform. From this
last step, the aqueous portion was mixed with 40 l of 3
M sodium acetate (pH 4.5) and 900 l of 96% ethanol, fol-
lowed by 30-min incubation at −20◦C and centrifuged (16
000 g, 20min, 4◦C). The supernatant was discarded, and the
pellet was washedwith 200l of ice-cold 70% ethanol, dried
in a SpeedVac and suspended in 50 l of 0.2% diethyl pyro-
carbonate (DEPC)-treated water. It was then treated with
20 units of RNase-free recombinant DNase I in DNase I
buffer and 20 units of Protector RNase Inhibitor (all from
Roche) for 30 min and at 37◦C. RNA was purified using
QIAGEN RNeasy Mini Kit and its quality and quantity
were assessed by gel electrophoresis and NanoDrop ND-
1000 (Thermo Scientific) using an extinction coefficient at
260 nm of 40 ng-cm/l.
An 8 × 15k microarray platform format (8 microarrays
per slide each with 15 000 probes) was designed using eAr-
ray (https://earray.chem.agilent.com/earray/; Agilent Tech-
nologies, Santa Clara, USA), and in each microarray spot
7316 out of the 7441 annotated genes in the M. xanthus
genome (excluding 79 RNA genes, 43 pseudogenes and
genes with duplicate annotations) were represented by 60-
bp amplicon probes (in duplicate and distributed randomly
per microarray, with empty array features filled with ran-
domly chosen amplicon probes). Total RNA isolated as
described above was checked for quality and quantity us-
ing the Agilent Bioanalyzer 2100 and the Prokaryote To-
tal RNA Nano assay, with those having an RNA integrity
number ≥ 7 chosen for further analysis. This RNA was
reverse-transcribed to yield cDNA that, after labeling with
the cyanine Cy3 (green) or Cy5 (red) fluorescent dyes (GE
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Healthcare), was hybridized to the microarray spot. Rela-
tive mRNA levels were determined using the Agilent two-
colormicroarray-based prokaryote analysis for gene expres-
sion protocols, version 1.3. For each test and reference con-
dition two or more independent microarray experiments
were performed and analyzed separately. Microarray hy-
bridization and data analyses were performed at Bioarray
SL (Spain). Hybridized microarrays were scanned and the
image analyzed to transform color intensity to numeric data
using the Agilent Feature Extractor Software v.10.7. Raw
intensity data were read and checked for quality using the
Limma package for R (51), corrected for background using
the normexp+offsetmethod (52), and normalized with loess
(intra-array) and quantile (inter-array) procedures (53). A
simple linear model was fit to the data and variances were
corrected using an empirical Bayes approach implemented
in the Bioconductor limma package (54). Genes were con-
sidered as significantly affected if they displayed a mean
log2 ratio < −1 or > +1 (corresponding to 2-fold change
up or down) relative to the control and with adjusted P-
values ≤ 0.05 (95% confidence limit) from two independent
array runs. Microarray data have been deposited at NCBI
Gene Expression Omnibus (GEO) with accession number
GSE112385.
Real-time quantitative reverse transcription PCR (qRT-
PCR)
Total RNA (2 g) isolated as above was reverse transcribed
to cDNA using random hexamer primers (Promega) and
Transcriptor Reverse Transcriptase (Roche) in a 20 l
reaction mix as per instructions. The cDNA sample (2
l) was added to a PCR mixture prepared using Power
SYBR® Green PCR Master Mix (Applied Biosystems)
that contained the respective primers at 100 nM. Reac-
tions were performed in triplicate for cDNA obtained
from each biological replicate; a control with an equiv-
alent volume of RNA, but not reverse transcribed, was
tested to rule out the presence of contaminant DNA.
Reported values are the average and the standard error
for three biological replicates. Primers (Supplementary Ta-
ble S3) to amplify ∼50–150 bp region within each tran-
script were designed (16S rRNA was the internal stan-
dard) using Primer3Plus (http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi). RNA quantitation was
carried out in an Applied Biosystems StepOne equipment
using the 1-StepRT-PCRprogram cycle without the reverse
transcription step.Melting and dissociation curves were de-
termined from 60–95◦C, 30 s and 95◦C, 15 s. Each primer
pair was tested for RT-PCR analysis on a standard curve
generated from five 10-fold serial dilutions of cDNA. Only
primer pairs with efficiency close to 100% were used and
data were analyzed using the Applied Biosystems system
software.
5′ RACE and RT-PCR analysis
Total RNAwas isolated from theddvA or wild-type (WT)
strain using High Pure RNA kit (Roche) or RNeasy Mini
kit (Qiagen) as described above, and RNA recovered after
two rounds of treatmentwith recombinantDNase I (Roche)
to fully eliminate genomic DNA was suspended in 50 l
RNase-free water (pre-treated with 0.2% DEPC). For 5′
RACE (rapid amplification of cDNA ends), 2 g of this
purified RNA was reverse-transcribed using an oligonu-
cleotide primer that hybridizes to the 3′ end of the gene
of interest and the 5′/3′ RACE 2nd Generation kit in
the presence of RNase inhibitor Protector (Roche). The
cDNA product was purified, tagged with a 5′ polyA adap-
tor and used as template in a PCR reaction with, as primers,
dT-Anchor and a cDNA-specific oligonucleotide that hy-
bridizes to the 3′ end of the gene of interest, followed by a
second PCR reaction with PCR Anchor instead of the dT-
Anchor. The product was purified using High Pure PCR
Product Purification Kit (Roche) and sequenced. For RT-
PCR, 500 ng total RNA was reverse-transcribed using ran-
domhexamers primers (Promega) andTranscriptorReverse
Transcriptase (Roche). A total of 2 l of the cDNA prod-
uct was used as template for subsequent PCR using primer
pairs that generate fragments of ≤500 bp spanning across
the junctions of the annotated cas genes or across the leader
to CRISPR4 spacers. As the negative (−RT) control, RNA
that was not subjected to reverse transcription, but other-
wise treated identically, was used as template in the PCR
reaction.
-galactosidase activity
Specific -galactosidase activity (in nanomoles of o-
nitrophenyl -D-galactoside hydrolyzed/min/mg protein
and at least three independent measurements) was per-
formed on cells grown in CTT to early exponential phase
or on cells undergoing development using a SpectraMax
340 microtitre plate reader (Molecular Devices), as de-
scribed elsewhere (45). X-Gal (5-bromo-4-chloro-3-indolyl-
-d-galactopyranoside)-agarose overlay assay for qualita-
tive analysis of reporter lacZ expression was carried out as
reported previously (50).
Chromatin immunoprecipitation-quantitative PCR (ChIP-
qPCR)
Cells grown in 50 ml CTT (with or without vanillate as re-
quired) at 33◦C to mid-late exponential phase (OD550 =
0.70) were treated with rifampicin (25 g/ml) for 30 min
and then cross-linked with formaldehyde (1% v/v; Sigma-
Aldrich) in the presence of 10 mM sodium phosphate (pH
7.6) for 10min at room temperaturewith shaking (100 rpm).
After cooling in ice for 30 min, cells were pelleted, washed
twice with phosphate-buffered saline solution and stored at
−80◦C until further use. For chromatin immunoprecipita-
tion (ChIP), the frozen pellet was thawed, resuspended in
lysis buffer (470 l, 10 mM Tris pH 7.5, 1 mM ethylenedi-
aminetetraacetic acid (EDTA), 100 mM NaCl, 2.2 mg/ml
lysozyme) and incubated at room temperature with shaking
(100 rpm) for 30min. It wasmixedwithChIP buffer (550l,
1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris pH 8.1,
167mMNaCl, 1XRoche complete protease inhibitor cock-
tail), incubated for 10 min at 37◦C and sonicated (sixty 30 s
on/30 s off cycles) in a Bioruptor (Diagenode) to generate
fragments of ∼0.5 kb. The sample was clarified by centrifu-
gation and an aliquot of 20 l supernatant was kept aside
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as the input sample. The rest was mixed with 550 l ChIP
buffer with 0.01% sodium dodecyl sulphate (SDS) and 5 l
of monoclonal anti-FLAG (Sigma-Aldrich) or anti-CarD
antibodies (46), incubated at 4◦C overnight with rotation
and immunoprecipitated (5–6 h, 4◦C) with rotation with 30
l of protein A magnetic Dynabeads (Life Technologies)
previously washed with PBS plus 1 mg/ml bovine serum al-
bumin. The beads were then washed once each with low salt
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM
Tris pH 8.1, 150 mMNaCl), the same buffer at 0.5MNaCl,
and with LiCl buffer (0.25 M LiCl, 1% NP-40, 1% sodium
deoxycholate, 1 mMEDTA, 10 mMTris pH 8.1), and twice
with TE buffer (10 mM Tris pH 8.0, 1 mM EDTA). The
protein–DNA complex was recovered in two 100 l frac-
tions of elution buffer (1% SDS, 0.1MNaHCO3) and incu-
bated at 65◦C for 10 min to disrupt the cross-links, treated
with 5 l proteinase K (20 g/l) at 42◦C for 2 h and at
65◦C for 6 h, followed by DNA isolation using High Pure
PCR product purification kit (Roche). The input sample
was also subjected to this cross-link reversal and DNA ex-
traction protocol. qRT-PCR was then carried out using the
SYBR Green reaction mix (BioRad) and specific primers
(Supplementary Table S3) in 0.1 ml MicroAMP FAST op-
tical 48-well reaction plates in a StepOne qPCR apparatus
(Applied Biosystems). Standard curves were obtained for
each DNA region of interest and its corresponding primer
pair with serial dilutions of the input DNA sample. Signal
enrichment at each promoter was estimated as: (i) percent of
input and normalized relative to the sample obtained with
cells lacking the immunoprecipitated protein; or (ii) ratio
of the promoter-specific to intragenic signals of ChIP re-
actions relative to the values for the input sample; the in-
tragenic region used as the non-promoter control spans nu-
cleotides 402–460 of the fruA gene (55). Reported values are
the mean and standard error from three independent exper-
iments.
Electrophoretic mobility shift assays (EMSA)
Purification of CarD, CarG andM. xanthusRNAP-A and
electrophoretic mobility shift assays (EMSA) were carried
out as described previously (45,56). The 32P-5′-end radiola-
beled double-stranded DNA probes used for EMSA were
obtained by PCR-amplification from plasmid constructs
bearing the required regions as DNA template. The DNA
probes thus obtained were: (i) 304-bp segments correspond-
ing to the entire CRISPR4 leader with the WT or mutant
(Mut) putative −35 promoter element at the leader, to test
for RNAP-A binding; (ii) 170-bp segments covering the
DdvS-dependent promoter regions, to test for CarD and
CarD–CarG binding. Samples (20 l) in EMSA buffer (80
mM KCl, 25 mM Tris pH 8.0, 5 mMMgCl2, 1 mM dithio-
threitol, 10% glycerol, 200 ng/l bovine serum albumin)
with 1g non-specific competitor poly[dG-dC] and 1 nMof
a given radiolabeled DNA probe (∼13 000 cpm) were incu-
bated for 30minwithRNAP-A (100 nM) at 37◦C, orCarD
(440 or 520 nM) with or without CarG (12 M) at 4◦C.
Then, to samples containing RNAP-A, heparin (1g) was
added and incubated for an additional 5 min to allow for-
mation of only heparin-resistant open promoter complexes,
followed by electrophoresis in 4% non-denaturing polyacry-
lamide gels at 200 V for 1.5 h in TBE buffer (45mMTris and
boric acid, 1 mM EDTA) at 10◦C. Gels were vacuum-dried
and analyzed by autoradiography.
Northern blot analysis of pre-crRNA and mature crRNAs
Total RNA from 5 ml cell cultures in CTT (OD550 = 0.6)
was isolated with 1 ml of Trizol reagent (Invitrogen) and 0.2
ml of chloroform (Sigma-Aldrich) and precipitated with 0.5
ml isopropanol (100%). The pellet was washed with 1 ml of
pre-cooled 75% ethanol, resuspended in 50 l of DEPC-
treated water and RNA concentration determined for pre-
crRNA analysis. To isolate RNA from fruiting bodies at
each time point analyzed, cells from 10 ml CTT cultures
(OD550 = 0.6) were washed and suspended in 2 ml TPM,
then distributed on four CF plates as 20 l spots and in-
cubated at 33◦C. At given times, developing cells were col-
lected in tubes containing 1 ml TPM and a 0.5 ml equiva-
lent of glass beads (0.1 mm diameter) for lysis using aMini-
beadbeater (BioSpec), andRNAwas recovered from the su-
pernatant as before. For mature crRNA detection, the total
RNA was resuspended in 300 l DEPC-treated water and
largeRNAmolecules were selectively precipitated out by in-
cubating with 5% polyethylene glycol 8000 and 0.5 MNaCl
for 30 min in ice. The supernatant, recovered by centrifuga-
tion, was mixed with 100% ethanol (three volumes) and 3
M sodium acetate (pH 5; 0.1 volume), incubated overnight
at −20◦C to precipitate small RNAs, washed twice with
80% ethanol, dried and resuspended in DEPC-treated wa-
ter. The RNA concentration was determined and northern
blot analysis of mature crRNAwas carried out as described
below.
To detect pre-crRNA, ∼20 g of total RNA obtained
above was electrophoresed in a 1.2% agarose gel with
20 mM MOPS/5 mM sodium acetate/1 mM EDTA/7%
formaldehyde buffer. The gel was washed with water (six
changes, 90 min), followed by capillary transfer to a Hy-
bondN+membrane (GELifesciences) overnight and cross-
linked by UV-irradiation (1.2 × 105 J/cm2; Hoefer UVC
500 apparatus). Pre-crRNA was detected using a radiola-
beled double-stranded 1044-bp DNA probe (spanning the
segment from CRISPR4 spacer 37 to spacer 52) gener-
ated using DNA polymerase I Klenow (Takara) and -
[32P]-dCTP (specific activity 3000 Ci/mmol) following stan-
dard protocols. 23S RNA, probed using a specific 1078-bp
double-stranded DNA probe, was used as the loading con-
trol. Probes were incubated at 95◦C for 5 min and rapidly
cooled in ice prior to use. The pre-crRNA blot was incu-
bated for 2 h at 65◦C in 0.9 M NaCl, 1% SDS, 100 g/ml
sheared, denatured salmon sperm DNA and hybridized
overnight at 65◦Cwith probe in fresh buffer containing 10%
dextran sulfate sodium salt and 50g/ml of the non-specific
DNA.After hybridization, the blots werewashed (3–5 times
over 20 min) with 0.3MNaCl, 0.03M sodium citrate (SSC)
buffer containing 0.1% SDS at 65◦C, and analyzed by au-
toradiography (Kodak X-OMAT film; intensifying screen
at−70◦C). For northern blots of mature crRNAs, RNA (10
g) free of large RNAs obtained above was electrophoresed
alongside 5′-end [32P]-radiolabeled RNA markers (Decade,
Ambion) in a 7 M urea-15% polyacrylamide gel (19:1
acrylamide:bisacrylamide) with TBE buffer, electrotrans-
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ferred to a Hybond N+ membrane (250 mA for 45 min
in TBE) and UV cross-linked as before. Single-stranded
synthetic DNA probes (20 pmol) to detect mature crRNA
corresponding to the CRISPR4 leader-proximal spacer
52 (5′-TGCATGAGTCGAAAGAGATTTTGAAGCGC
CGGAC-3′) and leader-distal spacer 1 (5′-GTCTGGCAA
CACCAGAATGGCGGAACCGACTA-3′) were 5′-end-
labeled with  -[32P]-ATP (6000 Ci/mmol specific activ-
ity; Perkin Elmer) and T4 polynucleotide kinase (Takara)
using standard protocols. The loading control was 5S
RNA probed with 5′-CTTAACTTCCGTGTTCGGGAT
GGGAACGGGTGGGAC-3′. The mature crRNA blot
was treated for 2 h at 30◦C with 40% formamide, 7%
SDS, 0.3 M NaCl, 0.05 M sodium phosphate pH 7 and
Denhardt’s solution (57) with 100 g/ml sheared, dena-
tured salmon sperm DNA (58) and hybridized with specific
probes in the same solution for 16 h at 30◦C. The blots were
washed with SSC buffer containing 0.2% SDS solution at
50◦C, and analyzed by autoradiography as before.
Bioinformatic analysis
Database searches and analysis were carried out with
BLASTN (for nucleotide sequences) and DELTA-BLAST
(for proteins) at http://blast.ncbi.nlm.nih.gov/Blast.cgi.
CRISPR-Cas data were analyzed using CRISPI
(http://crispi.genouest.org/; (59)) and CRISPRTarget (http:
//bioanalysis.otago.ac.nz/CRISPRTarget/crispr analysis.
html (60)). Genomic context and putative operons in the
M. xanthus genome were analyzed using Artemis software
(http://www.sanger.ac.uk/resources/software/artemis (61)).
Putative DdvS promoters within a maximum distance
to gene of 200 bp were identified in the M. xanthus
genomic region from positions 8909344 to 8883115
(∼26 kb at the ddvS–ddvA CRISPR4-Cas locus) with
as query the sequence GTAAn16CGT (n is any deoxyri-
bonucleotide) in Virtual Footprint Regulon Prediction
(http://prodoric.tu-bs.de/vfp; (62)). RNAfold (http:
//rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi;
(63)) and mfold (http://unafold.rna.albany.edu/?q=mfold;
(64) servers were used for secondary structure predictions.
RESULTS
The ECF  factor DdvS and the CarD–CarG global regula-
tory complex upregulate expression of the cas genes of a type
III-BM. xanthus CRISPR-Cas system
The ddvS–ddvA (genome locus tag MXAN 7289-
MXAN 7288) pair was first identified in an early Tn5
lac insertion analysis to screen for CarD-dependent genes
in M. xanthus and then shown to depend on CarG as well
(47,65). We demonstrated that DdvS is an ECF  factor
that drives its own expression and that of its translationally
coupled cognate anti-, DdvA, in a manner that requires
CarD and CarG; and that DdvA is a single-pass transmem-
brane protein, whose ∼70-residue cytoplasmic N-terminal
ZAS (zinc anti-sigma) domain physically interacts with
DdvS to sequester it and maintain it inactive ((42); Sup-
plementary Figure S3). DdvS and DdvA thus constitute
an ECF /anti- pair (42). Like typical anti- of ECF 
factors, inactivation of DdvA to release DdvS would be
expected to occur on sensing a specific external signal (40),
presumably via its large (∼900-residue) extracytoplasmic
domain (Supplementary Figure S3). Since the exact iden-
tity of such a signal is unknown, our strategy to identify
the DdvS regulon was to disrupt ddvA. Transcriptomic
analyses using WT M. xanthus and its derivative MR1543
with a Tn5 lac disruption of ddvA (ddvA− allele), and
MR1544 and MR1545 with deletions of carD (carD) or
carG (carG), respectively, were performed to assign differ-
entially expressed genes between these strains (‘Materials
and Methods’ section). Relative to the WT, about 40 and
63 genes were upregulated and downregulated, respectively,
in MR1543; and relative to the latter, 48 and 50 genes
were upregulated in MR1544 and MR1545, respectively,
while 142 and 127 genes were downregulated (Figure 1B
and Supplementary Table S4). Of the 40 genes that were
upregulated in MR1543, which could be directly or indi-
rectly activated by DdvS, 20 (including ddvS–ddvA) were
also downregulated in MR1544 and MR1545, indicating
that their expression not only depends on DdvS but also
on CarD and CarG (Figure 1B and Table 1). The majority
of these 20 genes cluster at the ddvS–ddvA locus and are
the ones with the highest fold-change in MR1543 relative
to the WT (6- to 600-fold change; Table 1 and Supple-
mentary Table S4). Two, MXAN 7291 and MXAN 7290,
lie immediately upstream of ddvS, are translationally
coupled and encode hypothetical proteins. The other 12,
downstream of ddvA, include four contiguous genes for
hypothetical proteins (MXAN 7287 to MXAN 7284) and
further downstream, interestingly, the cas (cmr) genes
(MXAN 7283 to MXAN 7276) of the CRISPR4-Cas type
III-B system, one of the three CRISPR-Cas systems in M.
xanthus (Figures 1A and 2A; Supplementary Figure S1).
An enhanced expression in MR1543 relative to the WT,
albeit lower, is also observed for five other genes at two
different loci (MXAN 1892: a putative serine-threonine ki-
nase; MXAN 1894: DNA-binding protein; MXAN 1810,
MXAN 1891 and MXAN 1893: hypothetical proteins).
Thus, microarray data suggest an unprecedented regulation
of a CRISPR-Cas system by an ECF /anti- pair and
a global regulatory complex, and we focused on this for
further analysis below.
Four DdvS-driven promoters dependent on CarD–CarG oc-
cur at the CRISPR4-cas locus
To understand how DdvS controls expression of the genes
in its vicinity, we first checked for the presence of DdvS-
dependent promoter(s) in the corresponding genomic re-
gion.We have previouslymapped the promoter of the ddvS–
ddvA operon, PddvSA and have shown by mutational anal-
ysis that the AA and GT at the −35 and −10 promoter
regions, respectively, are crucial elements ((42); Figure 2A
and B). These bases form part of the AAc and cGT motifs
(less conserved bases in lowercase) in the −35 and −10 re-
gions, respectively, shared by several promoters dependent
on other ECF  factors in M. xanthus (42), as well as in
other bacteria (66,67), with additional determinants around
these conserved motifs generally providing promoter se-
lectivity. An in silico scan of the M. xanthus genomic re-
gion spanning from ∼1 kb upstream of MXAN 7291 to
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Figure 2. Analysis of DdvS-dependent promoters. (A) Schematic of the Myxococcus xanthus CRISPR4-Cas system and the DdvS-dependent promoters
(right-angled arrows), PddvSA, and the three (PMXAN 7291, PMXAN 7286 and PMXAN 7283) identified in this study. Thick arrows (pointing in the direction
of transcription) in cyan are cas/cmr genes, as labeled, and thick unfilled arrows are genes encoding hypothetical proteins. CRISPR4 array repeats are
shown as black vertical bars and their spacers as colored bars. The leader (between cas6 and the array) is shown as a green line. (B) Sequences of PddvSA,
PMXAN 7291, PMXAN 7286 and PMXAN 7283 with the GTAA and CGT of the GTAAn16CGT pattern used in the in silico search in boldface, with a Weblogo
representation based on these below. The putative −10 and −35 regions were assigned by 5′-RACE mapping of the transcriptional start sites (+1 in bold;
see text and Supplementary Figure S4). For PMXAN 7283, the G at +1 and that of the annotatedMXAN 7283 initiator ATG codon coincide, suggesting that
the true initiator codon is probably an in-frame TTG eight codons downstream, which has a consensus ribosomal binding site. (C) Validation of transcript
levels using qRT-PCR of MXAN 7291, ddvS, MXAN 7286 and MXAN 7283 in the ddvA strain (MR1316) versus the WT (DK1050). (D) Same as in
(C) forddvAcarD (MR1317) (black bar) orddvAcarG (MR2384) (unfilled bar) versusddvA. Fold change is the mean and standard error of three
independent experiments. (E) Reporter lacZ expression (specific -galactosidase activity, ‘-Gal activity’, in nanomoles of o-nitrophenyl -D-galactoside
hydrolyzed/min/mg protein) of lacZ fusions to a fragment spanning positions (relative to the initiation codon of the corresponding gene): −400 to +63 at
PddvSA,−400 to +130 at PMXAN 7283 and at PMXAN 7286, and−292 to +197 at PMXAN 7291. Fusions are integrated at a heterologous site (see text) in theWT
(1),ddvA (2),ddvAcarD (3) andddvAcarG (4) strains. Activities correspond to the mean and standard error of three independent measurements.
∼1 kb downstream of the CRISPR4 array using as query
the sequence GTAAn16CGT, which matches that at PddvSA,
yielded three new hits. These were within 50 bp upstream
of the initiator codon of MXAN 7291, MXAN 7286, and
MXAN 7283 (Figure 2A and B), whose expression was up-
regulated by DdvS, CarD and CarG according to the mi-
croarray analysis (Table 1) and its further validation by
qRT-PCR (Figure 2C and D). The use of strains with a
ddvA allele (in-frame deletion of ddvA) in the qRT-PCR
analysis, rather than the Tn5 lac disrupted ddvA− allele used
in the microarray analysis, may explain the different fold
changes. However, it is less clear why fold changes from
qRT-PCR for MXAN 7286 are larger than for the other
genes tested (Figure 2C andD). Nonetheless, both microar-
ray and qRT-PCR indicate that expression of all four genes
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MXAN 7291 Hypothetical protein 572.45 −4.66 −7.32
MXAN 7290 Hypothetical protein 285.32 −5.39 −4.15
MXAN 7289 DdvS 204.52 −5.75 −4.67
MXAN 7286 Hypothetical protein 122.96 −7.31 −8.73
MXAN 7283 Putative CRISPR-associated protein 66.61 −4.46 −4.25
MXAN 7282 CRISPR-associated RAMP Cmr1 family protein 65.46 −4.38 −4.09
MXAN 7285 Hypothetical protein/ThiF family protein 58.51 −7.15 −6.56
MXAN 7280 Putative CRISPR-associated Crm3 family protein 33.94 −3.40 −3.51
MXAN 7279 CRISPR-associated RAMP Cmr4 family protein 31.99 −3.11 −
MXAN 7277 CRISPR-associated RAMP Cmr6 family protein 25.10 −3.43 −3.09
MXAN 7284 Hypothetical protein 21.04 −5.27 −5.36
MXAN 7281 CRISPR-associated Cmr2/Cas10 family protein 18.32 −3.42 −3.62
MXAN 7276 CRISPR-associated Cas6 family protein 17.53 −3.25 −2.82
MXAN 7287 Hypothetical protein 8.61 −2.44 −2.32
MXAN 7288 DdvA 8.35 −2.92 −2.06
MXAN 7278 CRISPR-associated Cmr5 family protein 6.66 −2.88 −2.64
MXAN 1810 RDD family protein 3.50 −10.54 −3.61
MXAN 1893 Hypothetical protein 3.25 −7.52 −3.34
MXAN 1892 Putative serine/threonine protein kinase 3.16 −9. 49 −3.33
MXAN 1891 Hypothetical protein 2.69 −5.43 −2.96
MXAN 1894 DNA-binding protein 2.21 −3.05 −2.22
MXAN 5622 CarD − −55.39 −
MXAN 5623 CarG − − −20.37
FC: Fold-change in expression in the strain indicated first relative to the second strain listed. Note that the negative sign in the entries of the two ‘FC’
columns on the right is used to only indicate downregulation.
is DdvS/CarD/CarG-dependent, and this was further sup-
ported by the data below.
To corroborate that the new hits correspond to DdvS-
dependent promoters whose expression also requires CarD
and CarG, we fused DNA segments (∼500 bp) including
the putative promoters to a reporter lacZ gene in plas-
mid pMR3183 (50), which also contains a 1.38 kbM. xan-
thus DNA fragment with no promoter activity for inte-
gration into the chromosome at a heterologous site. Each
plasmid construct was introduced into the WT, ddvA,
ddvA carD and ddvA carG strains. All three fusions
(PMXAN 7291::lacZ, PMXAN 7286::lacZ and PMXAN 7283::lacZ)
exhibited significant reporter lacZ activity in the ddvA
strain, like the positive control PddvSA::lacZ (42), but little
or no activity in the WT, ddvA carD or ddvA carG
strains (Figure 2E).Moreover, mapping of the transcription
start site in each of these constructs using 5′ RACE (‘Mate-
rials and Methods’ section) confirmed that the motifs iden-
tified from the sequence analysis corresponded well with the
−35 and−10 promoter regions (Figure 2B and Supplemen-
tary Figure S4).
Direct action of DdvS and the CarD–CarG complex at
the four DdvS-dependent promoters would require them to
localize at these promoters in vivo, and we examined this by
ChIP-qPCR. For DdvS, we used a FLAG-tagged version
(shown to be functional in vivo; Supplementary Figure S5A)
to enable immunoprecipitation with anti-FLAGantibodies.
Furthermore, to achieve stimulus-independent activation of
FLAG-DdvS and allow its conditional expression, the gene
was placed under the control of a vanillate-inducible pro-
moter and integrated into the chromosome at the heterol-
ogous site mentioned earlier (50). The induced expression
of DdvS alone overcomes the stoichiometric sequestration
by DdvA to provide free and active DdvS (42). ChIP-qPCR
analysis using anti-FLAG antibodies of cells grown to mid-
exponential phase in the presence of vanillate, and treated
with rifampicin to trapRNAP complexes at promoters (68),
revealed a six to seven-fold enrichment of DdvS at all four
DdvS-dependent promoters relative to cells grown without
vanillate (Figure 3A).
Since CarD and CarG always act in concert as a sta-
ble complex (45,47), we tested whether the complex lo-
calizes in vivo at these promoters by immunoprecipitating
its CarD component from the WT, ddvA, ddvA carD
andddvAcarG strains using anti-CarDmonoclonal an-
tibodies (46). This ChIP-qPCR analysis revealed about a
5-fold enrichment of CarD, relative to the ddvA carD
strain (the negative control), at all four promoters in the
ddvA but not in the WT or ddvA carG strains (Fig-
ure 3B); comparable data were obtained when tested us-
ing an intragenic region, where CarD is not expected to be
enriched (Supplementary Figure S5B). The data thus indi-
cate that in vivoCarD preferentially localizes at these DdvS-
driven promoters when actively transcribed and if CarG is
also present, suggesting a direct positive role of the CarD–
CarG complex on the expression from these promoters. Lo-
calization of the CarD–CarG complex at these promoters
can be mediated by interactions, as noted in the Introduc-
tion, of CarDwithRNAP as well as withDNA. Since CarD
binds to the minor groove of AT-rich DNA and such AT-
rich regions occur in the vicinity of the DdvS-driven pro-
moters, we tested their binding in vitro to CarD alone or in
the presence of CarG. EMSA using DNA probes covering
these promoter regions confirmed the binding of CarD and
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Figure 3. DdvS and the CarD–CarG complex localize at fourDdvS/CarD/CarG-dependent promoters in vivo. (A) Occupancy of DdvS at the four promot-
ers. ChIP of FLAG-DdvS was performed using M2 anti-FLAG antibodies, and enrichment at each promoter is the percent input for cells with Pvan::flag-
ddvS at a heterologous site (strain MR2971) grown in the presence of vanillate (unfilled bars) relative to that in its absence (black bars). (B) ChIP-qPCR
data for enrichment of CarD at the four promoters. CarD was immunoprecipitated from cell cultures of strains DK1622, MR2590 (ddvA), MR2766
(ddvA carD) and MR2767 (ddvA carG) using monoclonal anti-CarD antibodies and enrichment at each promoter is the percent input relative to
the negative control (ddvA carD strain). Data are the mean and standard error from three independent experiments.
of the CarD–CarG complex (Supplementary Figure S5C
and D). Although CarD alone binds to DNA in vitro, its
enrichment at DdvS-dependent promoters in vivo proba-
bly owes to additional interactions with CarG and DdvS-
associated RNAP. Altogether, the above data establish the
presence of four promoters that depend directly on DdvS,
CarD and CarG in the vicinity of the CRISPR4-cas lo-
cus, one of which (PMXAN 7283) is directly upstream of the
cas/cmr cluster.
The CRISPR4 array leader has negligible promoter activity
The data above indicated that expression of the cas genes
of the CRISPR4-Cas system depends on DdvS and the
CarD–CarG complex but how the CRISPR4 array is tran-
scribed remained to be addressed. This has been described
to occur in some bacteria from primary 70/A-dependent
promoters located in the CRISPR leader (25,69), as noted
in the ‘Introduction’ section. Our inspection of the 304-bp
CRISPR4 leader sequence did not reveal any promoter re-
sembling PddvSA. However, we did notice a segment with a
TTGACA sequence spaced 17 bp from a TTTATG down-
stream (Figure 4A) that would conform well to the −35
and −10 elements, respectively, of known M. xanthus A-
dependent promoters (56,70). We therefore first tested if
this putative promoter is recognized in vitro using puri-
fiedM. xanthus RNAP-A holoenzyme in EMSA with 32P
5′-labeled DNA probes corresponding to the 304-bp WT
CRISPR4 leader segment or a variant (Mut) in which the
TTGof the putative−35 regionwasmutated toCCA. In the
assay, the labeled DNA probe and RNAP-A holoenzyme
were first incubated and heparin was then added to elim-
inate non-specific and closed promoter complexes, leaving
only stable, transcriptionally competent open promoter–
RNAP-A (RPo) complexes (56). This revealed a retarded
band with the WT probe that was barely detected with the
Mut probe (Figure 4B), suggesting that the proposed ele-
ments are recognized by RNAP-A in vitro.
Next, we tested if this putative promoter in the CRISPR4
leader was active in vivo by generating a plasmid construct
with a reporter lacZ gene fusion to the entire leader seg-
ment (Leader::lacZ) or with the leader bearing the mu-
tation at the −35 region of its putative A promoter
(Leader(Mut)::lacZ). The two plasmids were then indepen-
dently electroporated into the WT, ddvA, ddvA carD
and ddvA carG strains, where they would integrate at
the heterologous site mentioned earlier (Figure 4C). Both
fusions exhibited negligible reporter lacZ expression, and
hence promoter activity, in all four strains (Figure 4D),
which was surprising given that RNAP-A appeared to rec-
ognize in vitro the putative A promoter in the leader. Since
this lack of reporter activity might be due to absence of
some critical element(s) at the heterologous site, we gen-
erated plasmid constructs that allow integration of the re-
porter Leader::lacZ or Leader(Mut)::lacZ at the endoge-
nous site by homologous recombination, and introduced
them into the WT, ddvA, ddvA carD, and ddvA
carG strains (Figure 4C). Significant Leader::lacZ re-
porter activity was now observed in the ddvA strain but
not in theWT,ddvAcarD orddvAcarG strains, and
this remained unchanged with the Leader(Mut)::lacZ re-
porter (Figure 4D). Thus, the putative A promoter in the
leader has a marginal contribution, if any, to the expression
of the CRISPR4 array in vivo.
The CRISPR4 array is expressed by transcriptional
readthrough from the cas operon
Lack of promoter activity in the leader raises the possibil-
ity that transcription of the cas genes reads through the
leader into the CRISPR4 array. If so, DdvS, CarD and
CarG would coordinate transcription of the CRISPR4 ar-
ray with that of the cas genes. To test this, we first generated
strains with the appropriate genetic background in which
a promoter-less lacZ gene was fused downstream of cas6,
the gene at the 3′-end of the cas cluster and immediately
upstream of the 5′-end of the leader. Reporter lacZ was
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Figure 4. A putative A-dependent promoter in the CRISPR4 leader has negligible activity in vivo. (A) Sequence of the 304-bp leader segment extending
from the cas6 3′-end to the first CRISPR4 repeat (italics and boxed). The putative A-promoter −35 and −10 elements are indicated. (B) Representative
EMSA gel for the binding of RNAP-A (100 nM) to the 5′-end 32P-labeled 304-bp WT leader probe and its variant (Mut) with TTG of the −35 element
of the putative A-promoter mutated to CCA. Samples were incubated at 37◦C in the presence of poly[dG-dC] as non-specific competitor for 30 min
and then, after adding 1 g heparin, for a further 5 min, followed by electrophoresis. (C) Schemes for the strategy used to introduce in the WT, ddvA,
ddvA carD or ddvA carG strains a Leader::lacZ or a Leader(Mut)::lacZ reporter fusion (Mut is the same as in B) at a heterologous (left) or at the
endogenous site (right). The plasmid construct bearing Leader::lacZ (pMR4334) or Leader(Mut)::lacZ (pMR4385) was electroporated into the desired
strain and colonies resulting from plasmid integration by recombination (dashed gray lines) at the heterologous 1.38 kb site were selected using the KmR
marker. Alternatively, a plasmid construct bearing cas6-Leader::lacZ (pMR4351) or cas6-Leader(Mut)::lacZ (pMR4402) was electroporated and colonies
resulting from plasmid integration at the endogenous locus by recombination (dashed gray lines) were selected using the KmR marker. (D) Expression
of the Leader::lacZ or Leader(Mut)::lacZ reporter fusions (-Gal activity, as the mean and standard error of at least three independent measurements)
introduced into the M. xanthus genetic backgrounds indicated at the heterologous (strains MR2777-MR2780; MR2797-MR2799 and MR2851) or the
endogenous site (strains MR2781-MR2784; MR2852-MR2855).
highly expressed in the ddvA strain but not in the WT,
ddvA carD or ddvA carG strains (Figure 5A), sug-
gesting that the DdvS-dependent transcription from cas6
reads through downstream. Interestingly, this lacZ activ-
ity in the ddvA strain was ∼3-fold higher than for the
Leader::lacZ fusion at the endogenous site (see Figure 4D),
suggesting that the leader reduces its expression. This may
be because proteins that bind to the leader (Cas1/Cas2,
H-NS, IHF have been shown to do so in other bacteria;
(1,25)) impede transcription, and/or because the predicted
leader RNA secondary structure (Supplementary Figure
S6A; (71)) hinders translation.
The relative positioning of the cas genes, with predicted
start and stop codons overlapping (cmr1-cmr2, cmr3-cmr4,
cmr4-cmr5, cmr5-cmr6 and cmr6-cas6 pairs), or apart by
only 2 bp (cmr2-cmr3) or 4 bp (MXAN 7283-cmr1), sug-
gests that they form an operon, and hence would be ex-
pected to be transcribed as a polycistronic mRNA from
PMXAN 7283 (immediately upstream of the cas/cmr cluster).
To confirm this, we isolated total RNA from the ddvA
and WT strains and analyzed it by RT-PCR using appro-
priate primers to amplify regions across the junctions be-
tween different cas genes and, to check for transcriptional
readthrough into the CRISPR4 array, from cas6 to the first
or second leader-proximal spacers (Figure 5B). Specific RT-
PCR products were detected with RNA from the ddvA
strain but not in controls with the RT step omitted or with
RNA isolated from the WT strain (Figure 5B). This indi-
cates that the cas genes are transcribed as a polycistronic
mRNA that reads through the leader into the CRISPR4 ar-
ray, and that this occurs once DdvS is active.
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Figure 5. Transcriptional readthrough of the DdvS-dependent cas operon into the CRISPR4 array. (A) Scheme of the strategy used for introducing a
CRISPR4 cas6-reporter lacZ fusion at the endogenous locus into the WT, ddvA, ddvA carD or ddvA carG strains. A plasmid construct bearing
the cas6::lacZ fusion (pMR4384, which also includes 440 bp of cmr6 to facilitate integration at the endogenous site) was electroporated into the given strain
and colonies resulting from plasmid integration at the endogenous locus by homologous recombination (dashed gray lines) were selected using the KmR
marker (strains MR2793-MR2796). Reporter lacZ expression (-Gal activity) is the mean and standard error of at least three independent measurements.
(B) RT-PCR analysis of RNA isolated from the ddvA and WT strains. The scheme of CRISPR4-cas system on top indicates the span of this locus
and of the regions (numbered lines with size, in bp, in parentheses) analyzed by RT-PCR. Spacers are numbered in descending order in the direction of
transcription from PMXAN 7283; thus, the first spacer from the 3′-end of the leader is numbered 52 and the last (farthest) spacer from the leader is numbered
1. RNA isolated from the indicated strain and reverse transcribed (+) or not (−; the negative control) served as the template to amplify the indicated
regions. PCR products were analyzed in agarose gels alongside size markers.
Mature CRISPR4 crRNA biogenesis is controlled by DdvS,
CarD and CarG
CRISPR arrays transcribed from a promoter in its leader
region generate pre-crRNA, which is then processed to
smaller, mature crRNAs. In the case of the CRISPR4 array,
transcriptional readthrough from the upstream cas genes
would be expected to result in a large transcript (of at
least ∼12 kb) encompassing the cas operon transcript and
the ∼4 kb pre-crRNA. To examine if this transcript can
be detected, we isolated total RNA from the WT, ddvA,
ddvA carD and ddvA carG strains, and carried out
a Northern blot analysis using an ∼1-kb probe spanning
CRISPR4 spacers 37–52. We also performed the analysis
with a ddvA strain bearing a copy of ddvA under the con-
trol of an IPTG-inducible promoter (PIPTG::ddvA) at the
heterologous site mentioned before, which allows ddvA ex-
pression (and hence presence) to be turned on or off as re-
quired, and testing if DdvA can function when supplied
in trans (Figure 6A). The Northern blot revealed a smear
of progressively increasing signal intensity extending from
>4 to <0.2 kb (where the signal was most intense) for the
ddvA strain and its derivative with PIPTG::ddvA grown in
the absence of the inducer IPTG (Figure 6A). By contrast,
this was not observed for the WT, ddvA carD, ddvA
carG or the ddvA PIPTG::ddvA strain grown in the pres-
ence of IPTG, although in each case a weak band appeared
between 3 and 4 kb. To check if this weak signal corresponds
to pre-crRNA, perhaps due tomarginal expression from the
putative A-dependent promoter in the leader, we gener-
ated strains with the CRISPR4 array deleted in theWT and
ddvA genetic backgrounds. The presence of the band even
when CRISPR4 is deleted indicates that it must be a non-
specific background signal (Figure 6A). The smeared signal,
with RNAmolecules<0.2 kb contributing overwhelmingly,
observed for strains devoid of DdvA (which can function
in trans) but not of CarD or CarG, suggests that the large
initial transcript is rapidly processed to mature crRNAs,
whose production was examined next.
To detect mature crRNAs generated due to transcrip-
tional readthrough from the upstream cas genes into the
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Figure 6. CRISPR4 crRNA analysis and its dependence on DdvS, CarD
and CarG. (A) Northern blot analysis of total RNA isolated from the
strains indicated on top using a probe corresponding to the segment
spanning from spacers 37 to 52 of the CRISPR4 array. For the ddvA
PIPTG::ddvA strain (MR2959), RNA was isolated after growth in the pres-
ence (+) or absence (−) of IPTG. 23S rRNA (2973 nt) was probed (bottom
panel) as the internal loading control for each sample above. Size markers
are shown on the left. (B) Representative Northern blot to detect mature
CRISPR4 crRNAs by analyzing small RNAs isolated from the indicated
strains using probes corresponding to CRISPR4 spacers 52 or 1. 5S rRNA
(116 nt) probed as the internal loading control for each sample is shown
below.
CRISPR4 array, small RNAs isolated from each strain
above were analyzed in northern blots using short probes
corresponding to the CRISPR4 spacer 52 (the first spacer
from the leader 3′-end and the one most recently incorpo-
rated) or spacer 1 (the spacer farthest from the leader; Fig-
ure 5B and Supplementary Figure S2). With both probes,
an intense band at ∼40 nt and weaker ones at ∼45 nt and
at ∼35 nt, corresponding to mature CRISPR4 crRNAs,
were detected in the ddvA strain or its derivative with the
PIPTG::ddvA copy grown without IPTG (Figure 6B). That
signals were detected using the spacer 1 probe indicates that
transcription from the cas operon reads through the entire
CRISPR4 array. However, no crRNAs were observed in the
ddvA strain with the PIPTG::ddvA copy when grown in the
presence of IPTG, nor in the WT, ddvA carD or ddvA
carG strains (Figure 6B). Failure to detect any signal in
theddvA strainwithCRISPR4deleted confirms that these
crRNAs arise solely from this array (Figure 6B), while anal-
ysis using short probes complementary to those above indi-
cated that the CRISPR4 array is not transcribed in the op-
posite direction (Supplementary Figure S6B). Thus, mature
CRISPR4 crRNA biogenesis occurs only if DdvA is absent
and CarD and CarG are available, which is also when the
associated cmr/cas genes are expressed.
Biogenesis ofmature CRISPR4 crRNAs depends on theCas6
homolog of this type III-B system
The CRISPR4-cas and ddvS-ddvA loci have four genes
(MXAN 7287 to MXAN 7284) in between that encode
proteins of unknown function, and whose expression also
depends on DdvS, CarD and CarG (Figure 2A and Table
1). The concurrent expression of MXAN 7287-7284 with
that of CRISPR4-cas could imply a functional relationship
between them that may be manifested in mature CRISPR4
crRNA formation. To test this we deleted theMXAN 7287-
7284 segment in the ddvA strain with a PIPTG::ddvA copy
at the heterologous site, leaving the cas genes and its pro-
moter PMXAN 7283 intact (Figure 7A). Mature CRISPR4 cr-
RNA was detected at comparable levels in the resulting
strain and in that with intact MXAN 7287-7284 in the ab-
sence of DdvA (no IPTG), and was absent in both strains
upon IPTG-induced ddvA expression (Figure 7A). This in-
dicates that any functional link betweenMXAN 7287-7284
and the CRISPR4-Cas system is not at the level of mature
crRNA production.
As mentioned earlier, the most downstream gene in the
CRISPR4-cas cluster encodes aCas6 homolog, the endonu-
clease expected to cleave pre-crRNAwithin each repeat and
thus required to produce mature crRNAs. We tested this
and whether it can do so in trans, since Cas6 of type III-
B CRISPR systems reportedly acts in a standalone man-
ner (13,14). For this, we generated a strain with an in-frame
deletion of the CRISPR4 cas6 gene in a ddvA genetic
background and its derivative bearing a vanillate-inducible
copy of cas6 (Pvan::cas6) for conditional expression. North-
ern blots revealed that the mature CRISPR4 crRNAs ob-
served in the ddvA background were not detected when
cas6 was also deleted (ddvA cas6), and reappeared on
inducing Pvan::cas6 expression (Figure 7B). Northern blots
using the longer 1-kb probe yielded consistent data (Fig-
ure 7C). Absence of cas6, as in the ddvA cas6 strain
or the ddvA cas6 Pvan::cas6 strain grown without vanil-
late, yielded a detectable smear unlike the WT strain, but
without the highly intense signal at <0.2 kb that charac-
terized the ddvA strain or the ddvA cas6 Pvan::cas6
strain grown in the presence of vanillate. This suggests that
CRISPR4 transcripts produced in the ddvA background
are rapidly processed if Cas6 of this system is available, even
when Cas6 is supplied in trans, whereas these transcripts
are produced but not fully processed in the ddvA cas6
genetic background. Interestingly, in the latter, the decrease
in signal at<0.2 kb was not accompanied by a concomitant
increase in RNA species >0.2 kb, and the relatively lower
overall signal may be due to a somehow reduced expres-
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Figure 7. Cas6 dependence of mature CRISPR4 crRNA generation. (A) Scheme showing the ddvA PIPTG::ddvA strain (MR2959) and its derivative
(MR3177)with(87–84), where the segment encompassingMXAN 7287 toMXAN 7284 is deleted, leaving the cas genes and PMXAN 7283 intact.Northern
blot using probes corresponding to CRISPR4 spacers 1 and 52 comparing mature crRNAs produced in the ddvA PIPTG::ddvA strain and its (87–84)
derivative grown with and without IPTG. Below is the blot probing 5S rRNA as the internal loading control for each sample. (B) Northern blot analysis of
mature crRNAs using probes corresponding to CRISPR4 spacers 1 and 52 in the WT (DK1050), ddvA (MR1316), ddvAcas6 (MR2565) and ddvA
cas6 Pvan::cas6 (MR2862) strains; 5S rRNA was probed as the internal loading control for each sample. RNA was extracted for strain MR2862 grown
in the absence (−) or presence (+) of vanillate. (C) Northern blot analysis of CRISPR4 pre-crRNA, for strains as in (B), using a DNA probe spanning the
CRISPR4 segment from spacer 37–52. 23S rRNAwas probed as the internal loading control for each sample. (D) Northern blot analysis of mature crRNAs
using a probe corresponding to CRISPR4 spacer 52 in strains DK1622, MR2959, MR2962, MR2967 andMR3062, with relevant genotype indicated. The
ddvA strains used in this analysis have a PIPTG::ddvA copy at the 1.38 kb heterologous site but are denoted ddvA, for simplicity, as they were grown in
the absence of IPTG. The 5S rRNA was probed as the internal loading control for each sample. Strains with a vanillate-inducible copy of CRISPR4 cas6
(MR2967) or CRISPR2/3 cas6a (MR3062) were grown in the absence (−) or presence (+) of vanillate.
sion of pre-crRNA, or to the latter being more susceptible
to non-specific degradation in the absence of Cas6. Alto-
gether, these data indicate that Cas6 of the CRISPR4-Cas
system is required to process pre-crRNA formature crRNA
biogenesis.
Myxococcus xanthus contains a second Cas6 in the dis-
tinct type I CRISPR2/3-Cas system mentioned earlier that
houses the devTRS genes, whichWTcells reportedly express
under starvation, the stress that induces fruiting body de-
velopment (9,11,34). Interestingly, this Cas6 (hereafter de-
noted Cas6a to distinguish it from the other) shares high
(66%) sequence identity to that of the type III-B system,
and has an additional 27-residue N-terminal segment (Sup-
plementary Figure S7A). Moreover, the 36/37-bp CRISPR
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array repeats of the two systems differ at only two positions,
and the CRISPR3 and CRISPR4 leaders are 74% identical
(Supplementary Figures S1B and 7B). We therefore tested
if Cas6a can also process CRISPR4 pre-crRNA. Northern
blots revealed mature CRISPR4 crRNA in a ddvAcas6
strain supplied with a vanillate-inducible copy of cas6a
when grown in the presence of inducer (Figure 7D). These
results thus indicate that Cas6a can also target CRISPR4
pre-crRNA, consistent with the high sequence similarity be-
tween the two M. xanthus Cas6 proteins and with Cas6a
functioning in a standalone manner, as has been reported
for type I-A and type III-B systems (13,14). Our data, to-
gether with the other similarities noted above and a previ-
ous observation that a 79-bp stretch in the antisense strand
between the two CRISPR2/3 arrays is similar (with 14 mis-
matches) to a segment in MXAN 7283 of the CRISPR4-
Cas system (9), thus raise the possibility of crosstalk be-
tween the two M. xanthus CRISPR-Cas systems. Such
crosstalk has been observed for some, though not all, co-
existing type III-B and type I systems, despite their dis-
tinct modes of target interference: type I systems recognize
and degrade DNA targets, whereas type III systems recog-
nize nascent RNA transcripts that include a reverse comple-
ment of the crRNA sequence to degrade both the transcript
and its template DNA, a process described as transcription-
dependent DNA interference (72). Crosstalk between the
above two CRISPR-Cas systems in M. xanthus would re-
quire both to be simultaneously active. The CRISPR2/3-
Cas system is reportedly activated during fruiting body de-
velopment (9). Moreover, a gain-of-function transposon in-
sertion at the CRISPR4 array was reported to severely af-
fect the cell aggregation that precedes fruiting body forma-
tion, and it was speculated that this may be due to some
CRISPR4 transcripts targeting genes critical for develop-
ment (73).We therefore examined CRISPR4-cas expression
and mature crRNA biogenesis during fruiting body devel-
opment.
CRISPR4-cas expression is not activated by starvation
WT cells undergo a complex multicellular developmental
program on starvation to form mature, dark spore-filled
fruiting bodies, a process that is impaired in the carD
and carG strains (45,47). On starvation plates, the ddvA
strain produced normal fruiting bodies at similar times as
the WT but typically about half in number, in contrast to
the defective fruiting bodies of the carD strain used as
negative control (Figure 8A). Thus, fruiting bodies develop
even upon constitutive expression of DdvS, whose competi-
tion with other  factor(s) that usually act during develop-
ment may indirectly reduce the observed number of fruiting
bodies. To test whether starvation affects CRISPR4-cas ex-
pression, we first analyzed expression during development
of a lacZ reporter gene fused to the CRISPR4 leader at the
endogenous site (described earlier). This was done qualita-
tively by monitoring the appearance of a blue color in an
X-Gal overlay assay on starvation plates and quantitatively
by measuring -galactosidase activity. The ddvA strain,
in which the reporter lacZ is expressed during vegetative
growth, exhibited a pronounced blue color at time zero, as
expected, which persisted throughout development on star-
vation plates (Figure 8B); accordingly, the corresponding
-galactosidase activity was high and steady over the 0–24
h period examined (Figure 8C). For comparison, the late
developmentally regulated marker (4435; Supplementary
Table S2) increased sharply after 12 h post-starvation from
the very low levels at earlier times (Figure 8C). By contrast,
the blue color as well as the -galactosidase activity re-
mained marginal throughout development for the WT, just
as for the ddvA carD and ddvA carG strains used as
negative controls for CRISPR4-cas expression (Figure 8B
and C). To independently support these observations, we
performed Northern blot analysis of mature CRISPR4 cr-
RNAs of the WT and ddvA strains. Mature CRISPR4 cr-
RNAs were observed at even 48 h into development for the
ddvA strain, albeit at lower levels than at time zero, but not
for the WT at any of the times examined (Figure 8D). De-
spite these crRNAs being present, the ddvA strain forms
normal fruiting bodies, suggesting that the developmen-
tal defect caused by the transposon insertion at CRISPR4
mentioned above is unlikely to stem from expression of the
corresponding crRNAs, as was speculated. Altogether, our
data suggest that starvation, which inducesmulticellular de-
velopment, is not the trigger that activates CRISPR4-cas
expression and mature CRISPR4 crRNA biogenesis inM.
xanthus.
As noted earlier, the CRISPR2/3-Cas system, which in-
cludes the cas orthologs devTRS, has been reported to be
developmentally induced at low levels and enhanced by
disrupting the negative autoregulation by DevTRS (9,11).
The corresponding mature crRNAs would thus be expected
to appear in a developmental/DevTRS-dependent manner,
but this has not been previously examined.We therefore an-
alyzed this in Northern blots using a probe corresponding
to the leader-proximal spacer 22 of the CRISPR2/3-Cas
system (Figure 8D). Mature CRISPR2/3 crRNAs were not
detected in the WT, likely due to its reported low induc-
tion during development, since in thedevT strain we could
observe discrete signals (although of low intensity) at ∼90
nt, ∼150 nt and somewhat higher. These sizes are notably
larger than the 35–45 nt mature CRISPR4 crRNAs, despite
the comparable sizes of the repeats as well as of the spac-
ers, and the high sequence similarity between the repeats of
the two CRISPR systems and between their respective Cas6
homologs, both of which can act on CRISPR4 pre-crRNA
in trans to generate mature crRNAs of similar size (Fig-
ure 7D). The larger CRISPR2/3 crRNAs observed in the
devT strain may stem from differences in the final trim-
ming of these type I system RNAs relative to those of the
type III-B CRISPR4-Cas system (13,14), from incomplete
processing, or from lack of stabilization of the smaller ma-
ture crRNAs by an interference complex (Cascade) devoid
of DevT, a Cas8a1 homolog and likely component (11). Al-
together, these data indicate that the CRISPR4-Cas and the
CRISPR2/3-Cas systems are not simultaneously expressed
pre- or post-starvation in the WT (where neither system
is expressed) or under conditions favoring expression of
CRISPR4-cas (ddvA) or CRISPR2/3-cas (devT). Con-
sequently, there is little possibility of crosstalk between the
two CRISPR-Cas systems, at least under the conditions
tested. However, given the similarities between the two sys-
tems noted above, crosstalk could nonetheless occur when
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Figure 8. CRISPR-cas expression and starvation-induced fruiting body development. (A) Fruiting bodies formed by theWT (DK1622),ddvA (MR2590)
and carD (MR1900) strains after incubation at 33◦C for 24, 48 and 72 h on CF starvation plates. (B) An X-Gal overlay assay of WT (MR2781), ddvA
(MR2782), ddvA carD (MR2783) and ddvA carG (MR2784) strains, with a Leader::lacZ reporter at the endogenous CRISPR4-cas locus. Cells
were spotted on CF starvation plates and incubated at 33◦C for 12, 24 and 48 h, followed by an X-Gal overlay and examination after 2 h. (C) Activity
of a Leader::lacZ reporter at the endogenous CRISPR4-cas locus, in strains as in (B), from 0 to 24 h upon starvation. The developmentally-induced
4435::Tn5-lac (4435) insertion was used as a control. (D) Northern blot analysis to detect mature crRNAs isolated from the WT (DK1622), the ddvA
(MR2590) and the devT (MR3078) strains incubated on CF starvation plates for the indicated times. The 5S rRNA, probed as the internal loading
control for each sample, is shown below and size markers are indicated on the left.
both are active, although natural conditions for this, if any,
remain to be determined.
DISCUSSION
CRISPR arrays and associated cas genes must be first ex-
pressed for function. Controlling and coordinating this es-
sential step ensures that the machinery is active only when
needed, and limits the metabolic costs and unwanted ac-
cumulation of nucleases. The present study has uncovered
an unprecedented mechanism for regulated expression of a
CRISPR-cas system, which depends on an alternative ECF
 factor (DdvS), its cognate anti- factor (DdvA) and a
global regulatory complex (CarD–CarG). This tight multi-
factorial control of a type III-B CRISPR-cas system inM.
xanthus enables coordinated supply of all the CRISPR-Cas
components for mature crRNA biogenesis and its assembly
as an interference complex in vivo (Figure 9).
ECF  factors, small divergent members of the 70 su-
perfamily in bacteria, associate with RNAP to recognize
specific promoters for the expression of defined genes in
adaptive responses to various cell envelope and environ-
mental stress signals (39–41).We had previously established
that DdvS is kept inactive via its association with the cy-
toplasmic N-terminal ZAS domain of DdvA, a single-pass
membrane-associated protein, such that disruption of ddvA
or overexpression of ddvS provides free active DdvS for its
own CarD/CarG-dependent expression in vivo (42). The
specific natural signal that triggersDdvA inactivation to lib-
erate DdvS, and the set of genes (beyond ddvS and ddvA)
whose expression requires DdvS (its regulon) were, how-
ever, unknown. The current study has revealed that the
CarD/CarG-dependent DdvS regulon comprises primarily
a type III-B CRISPR-Cas system located in the proximity
of the ddvS-ddvA locus. The few other genes included in
the regulon encode products with unknown functions, un-
related to Cas proteins and whose role, if any, in CRISPR4-
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Figure 9. Model for regulatedCRISPR4-cas expression by theDdvS–DdvAECF-/anti- pair and theCarD–CarG regulatory complex. In theCRISPR4-
cas ‘OFF’ state, the ∼70-residue cytoplasmic, N-terminal ZAS domain of DdvA physically sequesters its cognate ECF- DdvS and impedes DdvS-driven
expression of the CRISPR4-Cas system. In the CRISPR4-cas ‘ON’ state, DdvA is inactivated by an external signal (that may be phage or foreign DNA)
freeing DdvS to associate with RNAP and activate, together with the CarD–CarG complex (the wavy line in CarD represents its DNA-binding domain),
expression from PMXAN 7283 (as well as from the other three DdvS/CarD/CarG-dependent promoters at the locus). This leads to simultaneous expression
of the cas genes and, by transcriptional readthrough, of the CRISPR4 array to produce a polycistronic mRNA encoding the Cas proteins comprising
the multiprotein Cmr complex, the endoribonuclease Cas6 and the pre-crRNA. Processing of pre-crRNA, dependent on Cas6, produces mature crRNAs,
which associate with the Cmr complex (represented based on available descriptions of other Cmr complexes) to form the ribonucleoprotein complex that
mediates interference.
Cas function is unclear. At least four of these, located
in the segment between ddvS-ddvA and the downstream
CRISPR4-cas operon, could be deleted with no apparent
loss of mature CRISPR4 crRNA production. We mapped
three new DdvS-driven CarD/CarG-dependent promoters
in this region, besides that previously identified for ddvS-
ddvA. One of these occurs immediately upstream of the first
gene of the cas cluster, and the other two are further up-
stream and drive the expression of genes encoding proteins
of unknown functions. These promoters are all silent un-
less DdvA is inactivated and, consistent with a direct ac-
tion, DdvS and the CarD–CarG complex localize in vivo at
these promoters when the latter are turned on. DdvS speci-
ficity for these promoters may stem from their conserved
GTAAn16CGTmotif and spacer length and the dependence
on CarD and CarG.
The exact molecular details on how CarD and CarG ex-
ert their positive role on DdvS activity (or on the activity
of a number of other ECF  factors in M. xanthus; (42))
remain enigmatic. Myxococcus xanthus has a large num-
ber of ECF  factors (∼45) and the activity of several of
these is modulated by the CarD–CarG complex, which is
thus an additional regulatory layer to the negative control
exerted by the cognate anti- factor (42). Since promoter
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recognition by ECF  factors usually adheres to consen-
sus −35 and −10 elements, variations from the consensus
and in the length (14–17 bp) and sequence of the spacer
between them determine ECF  promoter selectivity (39–
41,66,67). Regulation by factors like the CarD–CarG com-
plex, which could also contribute to promoter selectivity
(42), may enable DdvS to target its promoters. The CarD–
CarG complex binds to the minor groove of AT-rich DNA
sites using the intrinsically disordered CarD C-terminal do-
main, and to the RNAP -subunit through interactions
with the CarD N-terminal domain (44–48). Consequently,
the CarD–CarG complex may facilitate recruitment and/or
positioning of the RNAP-DdvS holoenzyme, once avail-
able, at target promoters through interactions with the pro-
moter proximal AT-rich DNA sites and with RNAP. Inter-
estingly, the CarDN-terminal domain is the foundingmem-
ber of a large family of bacterial RNAP-binding proteins
denoted CdnL, which play a crucial role in stabilizing tran-
scriptionally competent open promoter–RNAP complexes
formed at A-dependent promoters (56,74–76). That CarD
shares the RNAP recognition mode and some other cru-
cial functional determinants with CdnL (48) suggests that
its complex with CarG could have a similar stabilizing role
in transcription initiation at DdvS-dependent promoters.
The CRISPR4-Cas system, we show, is an operon with
the cas genes transcribed as a polycistronic mRNA that
reads through the leader segment into the CRISPR4 array
in a DdvS/CarD/CarG-dependent manner. Curiously, the
leader has a putative A-dependent promoter but whose ac-
tivity appears to be negligible in vivo. As a consequence, ex-
pression of the CRISPR4 array, whose leader lacks a DdvS-
dependent promoter, nonetheless requires DdvS, CarD and
CarG. This contrasts with most other CRISPR-cas systems
that have been studied, where transcription of the CRISPR
array, as with the cas genes, relies on promoters recognized
by RNAP holoenzyme containing the primary A factor.
Dependence on an ECF  factor (together with CarD and
CarG) to express cas genes aswell as theCRISPRarray thus
ensures simultaneous production of all the essential com-
ponents of the CRISPR4-Cas system upon receiving and
transducing the signal that leads to its activation.
How CRISPR-cas activation is triggered is clearly a crit-
ical step in its action, but the underlying mechanisms are
among those least characterized. In line with its role as the
anti- of an ECF  factor, DdvA would be at the fore-
front in sensing and/or transmitting a putative extracyto-
plasmic signal that would culminate in its inactivation to
liberate DdvS. Being membrane-associated, DdvA inacti-
vation is very likely accompanied by a perturbation of its
membrane environment. CRISPR-cas expression has been
previously linked to membrane stress, but the nature of the
actual cues involved remain speculative and the underly-
ing mechanisms complex and poorly understood (37,38).
Our data rule out one potential source of membrane stress
as the trigger for CRISPR4-cas expression and mature cr-
RNAgeneration, that stemming from the cellular differenti-
ation and morphological changes that occur on starvation-
induced fruiting body development of M. xanthus. Con-
ceivably, the large (∼900-residue) extracytoplasmic DdvA
C-terminal domain plays a crucial role in sensing the ex-
ternal signal and in the subsequent inactivation of DdvA.
The sequence of this domain predicts an N-terminal region
with three tandem tetratricopeptide (TPR) repeat modules
that typicallymediate protein–protein interactions (77), and
a C-terminal CHAT (Caspase HetF Associated with Tprs)
family cysteine protease module (Supplementary Figure
S3). The CHAT domain is widespread in bacteria (78) but
remains poorly characterized, although a protease activ-
ity has been demonstrated for two such proteins, includ-
ing HetF, in cyanobacteria (79,80). An external signal in-
ducing protease action, with associated protein–protein in-
teractions, is a frequently employed mechanism for anti-
inactivation (40). For the DdvS–DdvA pair, this could be
orchestrated by the putative CHAT and TPR modules in
the DdvA C-terminal domain. A precedent for autoprote-
olysis of an anti- factor (unrelated to DdvA) has been re-
ported (81). Identifying the molecular mechanism involved
will require pinning down the signal triggering CRISPR4-
cas expression. One attractive possibility to pursue in future
studies is that the DdvA C-terminal domain is directly, or
indirectly, involved in phage recognition.
Deleting the cas6 homolog encoded by the CRISPR4-
Cas system abrogated mature crRNA formation, which was
restored on supplying this Cas6 in trans, indicating its re-
quirement for processing of the pre-crRNA. Intriguingly,
the Cas6 protein, the array repeats and the leader segment
of the CRISPR4-Cas system closely resemble those of the
type I-A CRISPR2/3-Cas system inM. xanthus (but share
no similarity with the third, uncharacterized CRISPR1-Cas
type I-C system). Also, the first cas gene of the CRISPR4-
Cas system has a 79-nt segment that coincides (with 14 mis-
matches) with a stretch in the region between the CRISPR2
and CRISPR3 arrays (9,34), and in several naturalM. xan-
thus isolates the type III-B CRISPR4-Cas system co-occurs
with the CRISPR2/3-Cas system (82). These similarities
suggest that the two systems likely share a common evo-
lutionary origin, and also raise the possibility of crosstalk
between them. Consistent with this, we found that Cas6a of
CRISPR2/3 supplied in trans could complement the lack
of CRISPR4-associated Cas6, suggesting that the two Cas6
homologs are functionally interchangeable. Any crosstalk
between the two CRISPR-Cas systems would require that
both are simultaneously active. However, CRISPR4-cas
expression is controlled tightly by DdvS, DdvA, CarD
and CarG, and is not induced by starvation, which trig-
gers multicellular development, whereas CRISPR2/3-cas
expression is regulated differently. It is silent during veg-
etative growth but induced upon starvation, although the
levels are low due to negative autoregulation of its pro-
moter Pdev (which is very different from PddvSA) by the prod-
ucts of three of its own cas genes (devTRS) (9,11). Consis-
tent with this, we found that mature CRISPR2/3 crRNAs
were undetected in the WT strain but appeared in a devT
strain during development, albeit at low levels and, pos-
sibly, incompletely processed. The devTRS products have
been shown to regulate the timing of sporulation during de-
velopment by preventing overproduction of the sporulation
inhibitor DevI (encoded by the first gene of the dev operon)
through negative autoregulation of dev transcription, pre-
sumably by a DevTRS Cascade-like subcomplex (11). This
was observed in the standard laboratory strain. However,
many natural M. xanthus isolates undergo normal devel-
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opment and sporulation despite lacking a functional Pdev
and devI, and DevTRS orthologs appear to be absent in
most other myxobacteria with proficient fruiting body de-
velopment (34,82), leading to the hypothesis that the rela-
tionship between a functional dev CRISPR2/3 system and
development may have evolved recently (11). The link, if
any, between CRISPR2/3 crRNA production and devel-
opment, however, remains an open issue. Nevertheless, at
least during development under the conditions tested with
the standard laboratory strain, our data do not indicate any
crosstalk between CRISPR4-cas and CRISPR2/3-cas ex-
pression,
An interesting alternative is that the two CRISPR-Cas
systems are linked via the more common role in phage im-
munity. It was recently reported that a type III-B CRISPR-
Cas interference complex could use not only its ownmature
crRNAs but also naturally co-opt those from a type I lo-
cus, despite differences in their repeat sequences, to counter
phage infection (72). The study proposed that plasticity in
crRNA utilization by type III-B systems may be a general
feature to supplement a co-existing type I system as an ad-
ditional line of defense (72). It was also noted that type
III systems often co-exist with type I systems in prokary-
otic genomes, and their greater tolerance to mutations in
target protospacer and flanking sequences can limit phage
escape effectively thus providing a back-up system against
phage invasion (72). It is thus noteworthy that the type
III-B CRISPR4-Cas system co-occurs with the type 1-A
CRISPR-Cas system in several naturalM. xanthus isolates
(82). In the M. xanthus CRISPR2/3-Cas system, the first
unique spacer downstream of the leader following the cas2
genematches perfectly with a sequence in the integrase gene
(intP) of bacteriophage Mx8 (Supplementary Figure S7C;
(9)), strongly hinting at a role of this CRISPR-Cas system
in defense against Mx8 or related viruses. Neither this nor
any of the other spacers in the CRISPR2/3 array occurs
in CRISPR4, whose spacers show no significant matches
to any known bacteriophage or plasmid DNA. It must be
noted that the genome sequence is available forMx8 but not
for any of the other M. xanthus phages that have been iso-
lated. It would therefore be interesting to examine if these
or other to-be-identified phages elicit a direct response from
the CRISPR4-Cas system, or indirectly through crosstalk
with the other two type I systems in M. xanthus. We are
therefore currently exploring these aspects and the possible
interplay with the DdvS–DdvA pair in these intriguing im-
mune systems.
In conclusion, our study has uncovered a novel regula-
tory mechanism for CRISPR-cas expression and crRNA
biogenesis that is based on the use of a specific ECF- and
its cognate anti-, together with a global regulatory com-
plex. This provides an elegant mechanism to detect an ex-
ternal signal such as phage or plasmid invasion, directly or
indirectly, by the anti- factor and couple it to anti- inacti-
vation and release of the ECF- factor for a coordinated ex-
pression of a CRISPR-cas cluster and mature crRNA gen-
eration.
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